Treatment with Barzolvolimab Improves DLQI Scores in All Domains in Patients with Chronic Inducible Urticaria

barzolvolimab (CDX-0159) - Celldex

https://eposters.aad.org/abstracts/76824

Martin Metz MD; Ana Maria Giménez-Arnau MD; Nazreen Hussen MD; Jurate Staikuniene-Kozonis MD; PhD; Tomas Slomskis MD; Essack Mitha MD; Usman Chaudhry; Haolan Lu PhD; Bradley Bloom MD; Jonathan A Bernstein MD

Mar 12, 2026